GILEAD In the Lead

8 mar 2020

Charting historical Support and Resistance levels. Gilead was on track to have an improved 2020 financials wise even before Corona Market. They are the front runner for vaccine in terms of drugs already in trials to treat similar COVID diseases. They also have two drugs being tested and waiting to be approved in China for cancer drugs which will continue to bolster stock if looking to hold long term. Many smaller biotech stocks with few to no results were losing value even in the bull market of last few months, now once Corona fears subside or companies have patented successful drugs, those companies will go back to losing their value and I think player like GILD are here to eat that up for those still looking to invest in biotech, but not penny stocks. Considering how manic this run up has been, the tests at the historical levels have been met and beaten, just not for as long as we'd like to see. Seems likely to have a small correction 03/09 as it's now at the level it was previously brought down sharply, but if mooning through 82.50 without dropping below 78.50 then it's clear to have another discovery between 85-90.
Summary:
Good long term investment. Good swing trade. Scalping could cause a shortened lifespan, though huge room for profit (and loss =D)